Work

Abstract 7172: Combination of B7-H4-TOP1i ADC, PD-1/TIGIT bispecific antibody, and PARP inhibition orchestrates angiogenesis suppression and interferon-program activation in a syngeneic mouse model

Year: 2026

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2026-7172

Authors: Octavio Morante-Palacios, Jon Chesebrough, Yoshimi Johnson, Raymond Rothstein, Varsha Shankarappa, Joseph Boland, Elizabeth Galery, Anna Dominika Staniszewska, Mark R. Albertella, Alex Cazes, Paul Chariou, Bilal Omar

Institutions: AstraZeneca (Spain), AstraZeneca (United Kingdom)

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7148646786

Cites:

Cited by: 1

Related to: